129.53
전일 마감가:
$125.64
열려 있는:
$126.665
하루 거래량:
1.05M
Relative Volume:
0.20
시가총액:
$57.20B
수익:
$9.40B
순이익/손실:
$2.65B
주가수익비율:
21.82
EPS:
5.935
순현금흐름:
$2.24B
1주 성능:
+1.95%
1개월 성능:
+4.24%
6개월 성능:
-14.79%
1년 성능:
-21.24%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis Inc
|
129.80 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.48 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.22 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
480.51 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis Inc. (NYSE:ZTS) Q4 2025 Earnings Call Transcript - Insider Monkey
Assessing Zoetis: Insights From 5 Financial Analysts - Benzinga
Wealthfront Advisers LLC Purchases 13,097 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Q4 Earnings Call Highlights - Yahoo Finance
ING Groep NV Takes $4.58 Million Position in Zoetis Inc. $ZTS - MarketBeat
Will Zoetis Inc. outperform the market in YEARInsider Buying & Accurate Intraday Trading Signals - mfd.ru
Atria Investments Inc Trims Holdings in Zoetis Inc. $ZTS - MarketBeat
Jim Cramer on Zoetis (ZTS): “It Does Seem to Be Dead Money” - MSN
Decoding Zoetis Inc (ZTS): A Strategic SWOT Insight - GuruFocus
Zoetis Delivers Strong Q4 2025 Beat; Sets Sights on Long-Acting Growth in 2026 - AlphaStreet News
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Y - GuruFocus
Zoetis Inc. SEC 10-K Report - TradingView
Zoetis Stock Is In The Doghouse Despite Its Quarterly Beat; Here's Why - Investor's Business Daily
Zoetis (ZTS) Projects Strong FY26 Revenue and Net Income Growth - GuruFocus
Zoetis (ZTS) Surpasses Revenue Expectations in Q4, Highlights Fu - GuruFocus
Zoetis forecasts strong 2026 profit, revenue on steady pet-medicine demand - marketscreener.com
Zoetis Q4 2025 Earnings Beat Expectations - Intellectia AI
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide - Benzinga
Zoetis (ZTS) Q4 2025 Earnings: Strong International Growth and S - GuruFocus
How Investors May Respond To Zoetis (ZTS) Strong 2025 Results And Confident 2026 Earnings Guidance - Yahoo Finance
Zoetis (ZTS) Shares Dip Despite Beating Q4 2025 Expectations - GuruFocus
Zoetis (ZTS) Exceeds Q4 Expectations with Strong Earnings - GuruFocus
Zoetis forecasts upbeat 2026; pet‑care market pressure drags shares - TradingView
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 By Investing.com - Investing.com India
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 By Investing.com - Investing.com Nigeria
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 - Investing.com
Zoetis slips as outlook shows growth headwinds (ZTS:NYSE) - Seeking Alpha
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates - Nasdaq
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market - FinancialContent
Earnings call transcript: Zoetis beats Q4 2025 EPS forecast, stock dips - Investing.com
Fund Update: 113,803 ZOETIS (ZTS) shares added to South Dakota Investment Council portfolio - Quiver Quantitative
Jefferies reiterates Buy rating on Zoetis stock with $170 price target By Investing.com - Investing.com India
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 - Investing.com
Jefferies reiterates Buy rating on Zoetis stock with $170 price target - Investing.com
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance Singapore
Sector Update: Health Care - marketscreener.com
Zoetis (NYSE:ZTS) Updates FY 2026 Earnings Guidance - MarketBeat
Zoetis (ZTS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates - The Globe and Mail
Zoetis Inc. (NYSE:ZTS) Reports Q4 Earnings Beat and Steady 2026 Guidance - ChartMill
Zoetis Inc. Provides Earning Guidance for the Full Year 2026 - marketscreener.com
Zoetis stock rises after strong Q4 earnings and upbeat 2026 outlook - Investing.com Canada
Zoetis's (NYSE:ZTS) Q4 CY2025 Sales Top Estimates - Finviz
Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Rhumbline Advisers Has $163.07 Million Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis: Q4 Earnings Snapshot - kare11.com
Zoetis' Q4 Adjusted Earnings, Revenue Rise; Provides 2026 Guidance - marketscreener.com
(ZTS) Zoetis Expects 2026 Revenue Range $9.83B$10.03B, vs. FactSet Est of $9.92B - marketscreener.com
ZOETIS ($ZTS) Releases Q4 2025 Earnings - Quiver Quantitative
(ZTS) Zoetis Expects 2026 Adjusted EPS Range $7 to $7.10, vs. FactSet Est of $6.83 - marketscreener.com
Earnings Flash (ZTS) Zoetis Inc. Reports Q4 Revenue $2.39B, vs. FactSet Est of $2.36B - marketscreener.com
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):